The use of mesenchymal stem cells (MSCs) represents a promising approach to reduce tissue damage following pathophysiological events such as cardiac ischemia/reperfusion or stroke.^[@bib1],\ [@bib2],\ [@bib3]^ However, the positive results obtained in animal studies are not consistently reproduced in clinical trials,^[@bib4]^ suggesting that a better understanding of the mechanisms underlying the therapeutic actions of MSC may help to maximize their efficacy for therapeutic applications. Although it was initially thought that MSC repair injured tissues through direct differentiation, the latest reports indicate that MSCs aid tissue recovery via paracrine processes involving the secretion of soluble factors and shedding of extracellular vesicles like exosomes and microvesicles.^[@bib5]^ To enhance the therapeutic potential of MSC, the pharmacological or genetic manipulation of protective genes has been attempted. For example, MSC overexpressing heme oxygenase-1 (HO-1), the inducible defensive protein that degrades heme to biliverdin, iron and carbon monoxide, exhibit improved repairing ability in the ischemic heart.^[@bib6],\ [@bib7]^ This may relate to enhanced survival of stem cells once injected into the myocardium and to the intrinsic protective properties of HO-1 and its products, which exhibit antioxidant, anti-apoptotic and anti-inflammatory activities.^[@bib8],\ [@bib9],\ [@bib10]^ In addition, HO-1 may be critical in the recovery of cardiac tissue after ischemia, as it is involved in autophagy and mitochondrial biogenesis, leading to elimination of dysfunctional mitochondria^[@bib11],\ [@bib12]^ and replenishment with new healthy organelles.^[@bib13],\ [@bib14]^

Intriguingly, it has been recently discovered that MSCs rescue damaged somatic cells by transferring their own mitochondria through membrane thin channels referred to as 'tunneling nanotubes' (TNTs).^[@bib15],\ [@bib16],\ [@bib17],\ [@bib18],\ [@bib19],\ [@bib20]^ Mitochondrial transfer preserved aerobic respiration and ATP production of recipient cells, harboring mitochondria dysfunction in *in vitro* and *in vivo* protocols mimicking ischemia/reperfusion injury,^[@bib16],\ [@bib18]^ oxidative stress or inflammatory damage.^[@bib17],\ [@bib21]^ Importantly, Miro-1, a calcium-binding mitochondria Rho GTPase, was identified as a key mediator of MSC-derived organelle trafficking that enables the movement of mitochondria along microtubules present in TNTs.^[@bib22]^ The environmental cues that stimulate MSC to donate their own mitochondria to suffering cells are unknown. However, it is conceivable that stress signals originating from the recipient cells trigger MSC to effectuate mitochondrial transfer.^[@bib21],\ [@bib23]^

Interestingly, a new role for mitochondria as 'danger signals' following ischemia/reperfusion injury and severe tissue damage has been proposed.^[@bib24]^ In particular, mitochondria are liberated from dying cells in the surrounding environment and in the bloodstream where multiple mitochondrial products, such as mtDNA and *N*-formyl peptides, alert the whole organism of a 'danger' situation.^[@bib24],\ [@bib25],\ [@bib26]^ Thus, mitochondria and mitochondrial products are recognized as damage-associated molecular patterns (DAMPs) by specific receptors on immune and other cells, eliciting functional changes such as paracrine alteration of macrophages or accelerated maturation of dendritic cells.^[@bib27]^ Importantly, we and others found that suffering somatic cells, including cardiomyocytes, renal tubular cells or smooth muscle cells, release entire mitochondria inside MSC,^[@bib19],\ [@bib28],\ [@bib29]^ although the significance of this phenomenon is unknown.

Here we hypothesized that mitochondria from damaged cells are delivered to MSC, which respond to this danger signal by activating their reparative capacities. To test this hypothesis we used human multipotent adipose-derived stem cells (hMADS) as an MSC model, and co-cultured MSCs with endothelial or cardiac cells subjected to oxidative challenge with hydrogen peroxide (H~2~O~2~). We demonstrate that mitochondrial uptake and degradation within MSC are crucial for activating their rescuing properties *in vitro* and in a myocardial infarction model *in vivo*. We also delineate a molecular mechanism whereby mitochondria engulfed by MSC increase expression of HO-1, which directly controls the anti-apoptotic function of MSC by promoting mitochondrial biogenesis.

Results
=======

Encounter with mitochondria from damaged somatic cells triggers the anti-apoptotic functions of MSC
---------------------------------------------------------------------------------------------------

We first analyzed the transfer of mitochondria from RL14 cardiomyocytes or human umbilical vein endothelial cell (HUVEC) endothelial cells toward MSC in co-cultures where MSC and somatic cells were previously labeled with Wheat Germ Agglutinin (WGA) or MitoTracker Green, respectively. We found that the amount of somatic mitochondria up-taken by WGA^+^ MSC was higher in co-cultures with stressed cells compared to naive counterparts ([Figures 1a and b](#fig1){ref-type="fig"}). This phenomenon did not occur in co-cultures performed with somatic cells devoid of respiratory function through depletion of mitochondrial DNA (*ρ*0 cells). We then assessed the survival of RL14 or HUVEC cells after H~2~O~2~ exposure in the presence of MSC through Annexin V/7AAD staining. We confirmed that MSC enhanced the survival of suffering somatic WGA^−^ cells ([Figures 1c and d](#fig1){ref-type="fig"}). In contrast, MSC did not protect H~2~O~2~-injured RL14 or HUVEC cells in co-cultures made with somatic *ρ*0 cells or in the presence of transwell inserts (0.4 or 1 *μ*m) that prevented the bidirectional transfer of mitochondria between MSC and somatic cells^[@bib28]^ ([Figures 1c and d](#fig1){ref-type="fig"}). These observations indicate that the exchange of 'respiring' mitochondria from somatic cells to MSC is critical in the control of MSC anti-apoptotic function.

Damaged somatic cell-derived mitochondria promote rescue by enhancing the mitochondrial donor capacity of MSC
-------------------------------------------------------------------------------------------------------------

To determine whether delivery of mitochondria from damaged somatic cells stimulate MSC to donate their own mitochondria, we co-cultured MSC previously labeled with MitoTracker Green with untreated or H~2~O~2~-treated RL14 or HUVEC cells. We observed that the amount of MSC-derived mitochondria accumulated in somatic cells was higher after an H~2~O~2~ insult, but that no accumulation occurred in co-cultures performed with *ρ*0 somatic cells ([Figures 2a and b](#fig2){ref-type="fig"}). Furthermore, mitochondria delivered by MSC to somatic cells appeared functional, as transfer of mitochondria from MSC depleted in mtDNA (*ρ*0) or rendered dysfunctional through rhodamine 6G (R6G) treatment^[@bib30]^ failed to rescue the respiratory activity of H~2~O~2~-insulted cardiac or endothelial cells ([Figure 2c](#fig2){ref-type="fig"}) as assessed by measurements of pericellular oxygen ([Figure 2d](#fig2){ref-type="fig"} and data not shown). Taken together, these observations support the idea that mitochondria released by damaged somatic cells activate MSC to transfer healthy mitochondria toward dying cells. Consistently, increased transcriptional expression of Miro-1, a GTPase involved in mitochondrial trafficking,^[@bib22]^ was detected in MSC co-cultured with H~2~O~2~-injured HUVEC cells ([Figure 2c](#fig2){ref-type="fig"}). However, Miro-1 mRNA did not increase in co-cultures with normal MSC in the presence of transwell inserts or *ρ*0 HUVEC cells ([Figure 2c](#fig2){ref-type="fig"}).

Degradation of somatic cell-derived mitochondria inside MSC is necessary for triggering rescue
----------------------------------------------------------------------------------------------

To investigate the fate of somatic-derived mitochondria once engulfed by MSC, we performed transmission electron microscopy (TEM) on co-cultures with injured somatic cells and observed in MSC an important number of mitochondria trapped into vesicles resembling phagosomes ([Figure 3a](#fig3){ref-type="fig"}). Immunocytochemistry experiments also revealed in MSC co-cultured with damaged somatic cells that a significant amount of mitochondria were co-localized with LC3B-stained autophagosomes ([Figure 3a](#fig3){ref-type="fig"}). This suggested that foreign mitochondria coming from damaged somatic cells are digested by MSC. To test this hypothesis, LC3B protein expression and autophagy activity were measured by immunocytochemistry, western blotting and Cyto-ID flow cytometry in different conditions. MSC mixed with H~2~O~2~-insulted RL14 or HUVEC cells expressed higher total LC3B and cleaved LC3-II protein levels and increased autophagic activity than those co-cultured with intact somatic cells ([Figures 3b and c](#fig3){ref-type="fig"}; [Supplementary Figures 1a and b](#sup1){ref-type="supplementary-material"}). However, these phenomena did not occur in co-cultures with transwell inserts or *ρ*0 somatic cells ([Figure 3c](#fig3){ref-type="fig"}). To determine whether autophagy was responsible for degradation of H~2~O~2~-treated somatic-derived mitochondria into MSC, we measured MitoTracker Green-labeled somatic mitochondria accumulated after co-culture with naive MSC or MSC pretreated with chloroquine to impede mitophagy. We observed that the degradation of somatic mitochondria into MSC was significantly higher in co-cultures with H~2~O~2~-insulted RL14 or HUVEC ([Supplementary Figures 1c and d](#sup1){ref-type="supplementary-material"}). We also detected increased levels of cytosolic heme, presumably derived from the digested mitochondria, in MSC following co-culture with H~2~O~2~-insulted somatic cells compared to untreated conditions ([Supplementary Figures 1e and f](#sup1){ref-type="supplementary-material"}).

To address whether degradation of somatic-derived mitochondria was essential for the rescuing efficacy of MSC, we determined the ratio of surviving somatic cells following an H~2~O~2~ insult in co-cultures with MSC pretreated with the autophagy inhibitor chloroquine. Under these conditions, MSC significantly lost their ability to protect RL14 or HUVEC cells against H~2~O~2~-induced apoptosis ([Figures 3d and e](#fig3){ref-type="fig"}), suggesting that mitochondria from damaged somatic cells have to be degraded inside MSC in order to trigger their anti-apoptotic effects.

Damaged somatic cell-derived mitochondria stimulate the anti-apoptotic functions of MSC though the cytoprotective HO-1 enzyme
-----------------------------------------------------------------------------------------------------------------------------

Given that increased cytosolic heme was detected in MSC co-cultivated with H~2~O~2~-treated somatic cells, we examined whether the expression of HO-1, the inducible protein that degrades excess intracellular heme, was affected in MSC. We found that HO-1 expression and heme oxygenase enzymatic activity were significantly increased in MSC co-cultured with damaged RL14 or HUVEC cells than with intact somatic counterparts ([Figures 4a--c](#fig4){ref-type="fig"}). In contrast, HO-1 induction and heme oxygenase activity were markedly reduced in MSC co-cultured with injured *ρ*0 somatic cells or in MSC treated with chloroquine prior to co-culture ([Figures 4a--c](#fig4){ref-type="fig"}). These data suggest that digestion of somatic-derived mitochondria inside MSC leads to HO-1 upregulation.

We then determined whether HO-1 was involved in the control of MSC-rescuing activities. We performed co-cultures in the presence of tin protoporphyrin IX (SnPPIX), an inhibitor of heme oxygenase activity, and found that MSC markedly diminished the rescue of H~2~O~2~-injured RL14 or HUVEC cells ([Figures 4d and e](#fig4){ref-type="fig"}). These results support that HO-1 mediates the anti-apoptotic function of MSC.

HO-1 promotes the anti-apoptotic response of MSC through stimulation of mitochondrial biogenesis
------------------------------------------------------------------------------------------------

Because HO-1 is known to stimulate mitochondrial biogenesis,^[@bib13],\ [@bib31]^ we reasoned that this process might underlie the rescue efficiency of MSC by favoring the transfer of their healthy mitochondria toward damaged cells. Thus, we examined whether MSC mitochondrial mass was affected by co-culture with damaged cells. We observed an increased MitoTracker Green fluorescence, reflecting enhanced mitochondria content, in MSC co-cultured with H~2~O~2~-injured RL14 or HUVEC cells compared to healthy somatic counterparts ([Figure 5a](#fig5){ref-type="fig"}). No increase in MSC mitochondrial mass was detected in co-cultures performed with *ρ*0 RL14 or HUVEC cells or in MSC treated with chloroquine or SnPPIX to block autophagy or heme oxygenase activity, respectively ([Figure 5a](#fig5){ref-type="fig"}). Consistently, the mRNA expression of two master regulators of mitochondrial biogenesis, PGC1-*α* (peroxisome proliferator-activated receptor gamma coactivator-1-*α*) and mtTFA (mitochondrial transcription factor A), was elevated in MSC co-incubated with H~2~O~2~-insulted somatic cells ([Figure 5b](#fig5){ref-type="fig"}). mtTFA protein expression was also higher in MSC co-cultured with injured RL14 or HUVEC cells compared to healthy somatic cells ([Figures 5c and d](#fig5){ref-type="fig"}). Co-cultures conducted with H~2~O~2~-damaged *ρ*0 RL14 or HUVEC cells or with MSC, where autophagy or heme oxygenase activity was inhibited, prevented mitochondrial biogenesis stimulation in MSC ([Figures 5a--d](#fig5){ref-type="fig"}). Altogether, these results indicate the following: (1) mitochondrial biogenesis is stimulated in MSC in response to a crosstalk with damaged somatic cells; (2) this process is a consequence of phagocytosis of engulfed somatic-derived mitochondria; and (3) the process is dependent on HO-1 activity.

Finally, to determine whether mitochondrial biogenesis was required for eliciting the rescue properties of MSC, co-cultures of MSC with H~2~O~2~-damaged RL14 or HUVEC cells were performed in the presence of 2′,3′-dideoxycytidine (ddC), an inhibitor of DNA polymerase *γ* that controls mtDNA replication.^[@bib32]^ We show that ddC significantly decreased the ability of MSC to protect damaged somatic cells from apoptosis ([Figures 5e and f](#fig5){ref-type="fig"}).

ROS and mitochondrial dynamic are involved in the rescue response of MSC toward doxorubicin-damaged somatic cells
-----------------------------------------------------------------------------------------------------------------

To determine whether somatic mitochondria transfer into MSC is common to other stressful conditions or was specific to ROS (H~2~O~2~) injury, we performed co-cultures with somatic cells exposed to doxorubicin, another damaging agent. Similarly to H~2~O~2~, doxorubicin-damaged RL14 or HUVEC cells increased their mitochondria release toward MSC ([Figure 6a](#fig6){ref-type="fig"}) and were rescued by MSC ([Figure 6b](#fig6){ref-type="fig"}). An enhanced delivery of mitochondria also occurred from MSC toward suffering cells ([Figure 6c](#fig6){ref-type="fig"}). Furthermore, increased autophagic activity was detected in MSC ([Figure 6d](#fig6){ref-type="fig"}; [Supplementary Figures 1a and b](#sup1){ref-type="supplementary-material"}) together with enhanced degradation of somatic-derived mitochondria, cytosolic heme content ([Supplementary Figures 1c--f](#sup1){ref-type="supplementary-material"}) and expression of HO-1 and mtTFA proteins ([Figures 6e and f](#fig6){ref-type="fig"}).

As ROS are linked to stimulation of HO-1 and mitochondrial biogenesis,^[@bib33]^ we investigated whether ROS from damaged somatic cells were involved in mitochondria signaling and MSC-mediated rescue. By using Mitosox dye staining we revealed that damaged somatic mitochondria transferred into MSC produced higher ROS levels compared to untreated conditions ([Figure 6g](#fig6){ref-type="fig"}). In doxorubicin-injured somatic cells pretreated with *N*-Acetyl-*L*-Cysteine (NAC), a ROS scavenger, mitochondria transfer to MSC was markedly attenuated ([Figure 6a](#fig6){ref-type="fig"}). Interestingly, pretreatment with NAC prevented the rescue properties of MSC ([Figure 6b](#fig6){ref-type="fig"}), as induction of mitochondria delivery to somatic cells ([Figure 6c](#fig6){ref-type="fig"}) and activation of autophagy, HO-1 expression and mitochondrial biogenesis ([Figures 6d and f](#fig6){ref-type="fig"}) were all impaired. These findings indicated that ROS produced by somatic cells following damage stimulate mitochondria delivery to MSC to trigger an adaptive cytoprotective response.

Recent findings associate mitochondrial fusion/fission with mitophagy, mitochondrial biogenesis and HO-1.^[@bib34]^ Therefore, we investigated whether mitochondrial dynamic proteins participated in the MSC-mediated rescue once somatic-derived mitochondria were transferred and performed co-cultures with MSC treated with mdivi-1 or cccp to inhibit mitochondrial fission or fusion, respectively. Alteration of these two processes impaired the rescue properties of MSC ([Figure 6b](#fig6){ref-type="fig"}) and fusion inhibition in MSC, but not fission blockade, affected mitochondria delivery to suffering somatic cells and prevented induction of mitophagy, HO-1 or mitochondrial biogenesis in MSC ([Figures 6c--f](#fig6){ref-type="fig"}). Moreover, co-culture with suffering somatic cells stimulated the protein expression of mitofusin-1 and mitofusin-2 in MSC, and this process seemed to be dependent on HO-1 ([Supplementary Figures 2a--d](#sup1){ref-type="supplementary-material"}). Altogether, these results implicate mitochondrial fusion in MSC rescue activities, while mitochondrial fission seems to be involved by ensuring mitochondrial quality control to avoid the transfer of dysfunctional organelles.

Exposure of MSC to mitochondria isolated from somatic cells mimics the effects of co-culture
--------------------------------------------------------------------------------------------

To strengthen the hypothesis that somatic-derived mitochondria are the organelles that stimulate MSC-rescuing capacities, we investigated whether the effects of co-culture could be mimicked by exposure of MSC to exogenous somatic mitochondria. Mitochondria previously labeled with MitoTracker Green were extracted from RL14 cardiomyocytes and then conjugated to the cell-penetrating peptide Pep-1 to favor their entry in MSC.^[@bib35]^ After exposure for 24 h, increased MitoTracker Green fluorescence was detected in MSC, indicating the engulfment of exogenous mitochondria ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}). This engulfment process was also detected in naive and *ρ*0 somatic cells ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"}). Furthermore, exposure to exogenous mitochondria increased MSC autophagic activity (enhanced LC3B staining) in MSC compared to untreated MSC, including in the presence of chloroquine or a heme oxygenase activity inhibitor ([Figure 7a](#fig7){ref-type="fig"}). Active autophagy was also supported by an increased expression of cleaved LC3II proteins and decreased p62 in MSC treated with exogenous mitochondria compared to the untreated ones ([Figure 7b](#fig7){ref-type="fig"}). Exogenous mitochondria raised HO-1 protein expression ([Figure 7c](#fig7){ref-type="fig"}) and heme oxygenase activity in MSC ([Figure 7d](#fig7){ref-type="fig"}) accompanied by activation of PGC1-*α* (mRNA) and mtTFA (mRNA and protein levels; [Figures 7e and f](#fig7){ref-type="fig"}). The increased heme oxygenase activity and mitochondrial biogenesis were impaired in MSC exposed to exogenous mitochondria with chloroquine or SnPPIX ([Figures 7d--f](#fig7){ref-type="fig"}). Thus, it appears that exogenous somatic mitochondria are sufficient to cause in MSC the same phenotypic changes stimulated by co-culturing with suffering somatic cells. Finally, exposure to exogenous *ρ*0 mitochondria reproduced the effects of respiring ones as MSC autophagy as well as HO-1 and mtTFA protein expression were still induced ([Figure 7g](#fig7){ref-type="fig"}). This suggests that mtDNA-deficient mitochondria, like healthy mitochondria, can trigger signaling-protective pathway once engulfed in MSC. Indeed, exogenous healthy or mtDNA-depleted mitochondria restored the rescue ability of MSC toward H~2~O~2~-insulted *ρ*0 somatic cells ([Figure 7h](#fig7){ref-type="fig"}), suggesting that the lack of rescue observed in co-cultures with *ρ*0 somatic cells was due to a defect of *ρ*0 cells in delivering mitochondria to MSC.

MSC rescue infarcted hearts through an endosomal acidification and HO-1-sensitive mechanisms
--------------------------------------------------------------------------------------------

We investigated whether a crosstalk with damaged cells *in vivo* could also trigger MSC reparative capacities by delivering human MSC to either intact or infarcted mouse hearts and assessing the MSC phenotype after 24 h. We observed increased expression of HO-1 and PGC1-*α* genes in MSC infused in damaged hearts compared to MSC injected in intact myocardium while transcriptional expression of mtTFA was not changed ([Figure 8a](#fig8){ref-type="fig"}). Remarkably, upregulation of HO-1 and PGC1-*α* was not observed in MSC treated with chloroquine or SnPPIX prior to engraftment into infarcted hearts ([Figure 8a](#fig8){ref-type="fig"}). These results suggest that HO-1 expression and mitochondrial biogenesis are stimulated in engrafted MSC in response to myocardial injury and that MSC require proper autophagy activity to induce HO-1, which then activates mitochondrial biogenesis.

Notably, we demonstrated that human MSC protected cardiac tissue from cell death as plasma cardiac troponin t levels and intracardiac caspase-3 protein expression were significantly reduced in infarcted hearts of mice engrafted with naive MSC compared to hearts treated with saline Hank's Balanced Salt Solution (HBSS) solution ([Figures 8b and c](#fig8){ref-type="fig"}). Conversely, when phagocytosis or heme oxygenase activity was inhibited, engrafted MSC markedly lose their ability to protect cardiac tissue following ischemic damage ([Figures 8b and c](#fig8){ref-type="fig"}).

Discussion
==========

What are the signaling cues emitted by dying cells that activate the reparative functions of resident stem/progenitor cells to initiate wound-healing processes?^[@bib36],\ [@bib37]^ The identity of these cues is largely unknown and several 'danger' signals are likely responsible for MSC activation. In this study we addressed this question by considering preliminary observations from our laboratory, showing that MSC engulfed foreign mitochondria when co-cultured with suffering somatic cells.^[@bib28]^ We reasoned that mitochondria from damaged cells could be one of the cues, in line with emerging evidence indicating that mitochondrial products act as DAMPs to alert the organism of a danger situation.^[@bib24],\ [@bib25],\ [@bib26]^ By analyzing the interaction of mitochondria with MSC and the subsequent molecular events, we demonstrate that mitochondria transferred from dying somatic cells and, once digested in MSC, activated the cytoprotective protein HO-1. This led to increased mitochondrial biogenesis that allowed MSC to donate healthy mitochondria, thereby enhancing survival of suffering cells. Thus, mitochondria released by damaged somatic cells appear to act as master regulators of MSC functions.

Severe tissue injury following many types of stress causes rapture of cell membranes and release of intracellular components in the surrounding environment. Therefore, although our data clearly show that mitochondria from damaged cells accumulated in MSC, other environmental cues may be sensed by MSC and activate their anti-apoptotic properties. However, our experiments with direct exposure to mitochondria isolated from somatic cells prove that mitochondria alone are sufficient to activate the MSC-rescuing ability. We previously reported that mitochondria from damaged cells were mainly conveyed to MSC via TNTs.^[@bib28]^ As apoptosis induced by oxidative stress was shown to promote TNT formation,^[@bib38]^ this could explain why injured cells delivered higher amounts of mitochondria to MSC in our co-cultures. Our experiments also indicate that mitochondrial ROS produced upon cell injury control the release of mitochondria from damaged somatic cells, as *ρ*0 somatic cells, which were unable to produce ROS and thus to adapt their mitochondrial flux following stress exposure, failed to elicit a cytoprotective response from MSC.

Capture of mitochondria by MSC stimulated autophagy, supposedly because MSC recognized somatic organelles as foreign bodies, and digestion of somatic-derived mitochondria was necessary for HO-1 induction and for eliciting MSC adaptive response. As mitochondria are rich in heme-containing proteins and heme is an inducer and substrate of HO-1 enzymatic activity, we were not surprised to detect increased MSC cytosolic heme content after co-cultures with damaged somatic cells, which likely led to HO-1 induction. Consequently, HO-1 initiated mitochondrial biogenesis in MSC as previously demonstrated by others.^[@bib13],\ [@bib14]^ This mechanistic scenario is plausible as blockade of authophagy failed to upregulate HO-1, thus preventing mitochondrial biogenesis and MSC activation. Similarly, inhibition of heme oxygenase activity prevented mitochondrial biogenesis and attenuated the protective response of MSC. Interestingly, this cascade of events exemplifies how MSC adapt their mitochondrial mass to ensure the rescue of suffering cells through donation of their own mitochondria and to simultaneously preserve their own energetic homeostasis. Importantly, mitochondria dynamic appeared to have a role in the rescue mediated by MSC by ensuring the quality control and functionality of the mitochondria transferred toward damaged somatic cells.^[@bib34]^ That the above mechanisms have physiological relevance was confirmed by our *in vivo* experiments in mouse myocardial infarction, where human MSC engrafted in the heart enhanced autophagy activity, HO-1 expression and mitochondrial biogenesis, and inhibition of these processes impaired their tissue-protective effects. Even though we identified that HO-1 is directly linked to enhancing the capacity of MSC to donate their mitochondria, further biological actions of this enzyme and its products, such as its pro-angiogenic^[@bib39],\ [@bib40]^ and anti-inflammatory properties,^[@bib41],\ [@bib42],\ [@bib43]^ could contribute to this effect. Furthermore, other stress proteins and pro-survival systems are likely engaged by MSC to execute their reparative action. Collectively, our findings highlight that mitochondria, released from somatic cells as a result of tissue injury, act as signaling organelles capable of awakening MSC from a dormant state into a pro-healing phenotype and uncover novel molecular mechanisms that illustrate how the crosstalk between somatic mitochondria and MSC stimulates a coordinated rescue response.

Importantly, exploitation of the mitochondria/HO-1 axis may help to develop innovative strategies to improve the therapeutic potential of MSC-based approaches.

Materials and Methods
=====================

Cell isolation and culture
--------------------------

HMADS cells used as human MSC model were isolated from adipose tissues obtained from young donors after informed parental consent as previously reported.^[@bib44]^ The human fetal ventricular RL14 cell line and primary HUVEC were purchased from the American Type Cell Culture (ATCC, LGC Standards S.a.r.l. Molsheim France) and PromoCell (Heidelberg, Germany), respectively.

HMADS cells were cultured in Dulbecco's modified Eagle's medium (DMEM), 1 g/l glucose, containing 10% heat-inactivated fetal bovine serum (FBS; Dominique Dutscher, Issy Les moulineaux, France), 100 U/ml penicillin, 100 *μ*g/ml streptomycin and 10 mM HEPES (Invitrogen, Carlsbad, CA, USA). As described earlier,^[@bib44]^ HMADS cells exhibited the following phenotype: CD44^+^, CD49b^+^, CD105^+^, CD90^+^, CD13^+^, Stro-1^−^, CD34^−^, CD15^−^, CD117^−^, Flk-1^−^, Gly-A^−^, CD133^−^, HLA-DR^−^ and HLA-I^low^.

Human RL14 cells were grown in DMEM/F-12 (Life Technologies, Carlsbard, CA, USA) supplemented with 12.5% heat-inactivated FBS, 100 U/ml penicillin, 100 *μ*g/ml streptomycin and 10 mM HEPES.^[@bib45]^ HUVEC cells were expanded on gelatin (2%)-coated dishes with the growth medium recommended and commercialized by the manufacturer (PromoCell). All cell types were maintained in a 5% CO~2~ atmosphere at 37 °C.

Generation of cells deficient in mtDNA (*ρ*^0^ cells) or in functional mitochondria
-----------------------------------------------------------------------------------

Depletion of mitochondrial DNA in MSC (hMADS cells), RL14 or HUVEC cells was achieved by growing cells in a medium additioned with ethidium bromide (Sigma-Aldrich, St. Louis, MO, USA) at 0.5, 2.5 or 5 *μ*g/ml, respectively, and supplemented with 50 *μ*g/ml uridine (Sigma-Aldrich) and 100 *μ*g/ml pyruvate (Sigma-Aldrich) for at least 1 month.^[@bib46],\ [@bib47],\ [@bib48],\ [@bib49]^ To quickly impair mitochondrial function, MSCs were treated with Rhodamine 6G (1 *μ*g/ml, Invitrogen) during 48 h as previously reported.^[@bib30]^

Oxidative stress treatments and co-culture settings
---------------------------------------------------

To induce apoptosis, RL14 or HUVEC cells were exposed to 600 *μ*M H~2~O~2~ or with 1 *μ*M doxorubicin (Sigma-Aldrich) for 2 or 24 h, respectively. Co-cultures were performed with MSC cells and naive or injured somatic cells at a density of 3500 cells/cm^2^ each (ratio 1 : 1) in DMEM supplemented with 10% FBS. To distinguish stem cells from somatic cells in mixed cultures, MSC cells were labeled with WGA conjugated to Alexa Fluor 647 (5 *μ*g/ml; Life Technologies) prior to co-culture. Single cultures of RL14, HUVEC or MSC were performed in the same medium and at the same concentration. Separation of co-cultures was performed using cell culture inserts containing polycarbonate membrane (0.4 or 1 *μ*m size pore, Millicell, Millipore). To scavenge mitochondrial ROS, somatic cells were treated with 1 mM NAC (Sigma-Aldrich) for 24 h prior to the co-culture. To inhibit mitochondrial fusion and fission, MSCs were treated with 10 *μ*M Carbonyl Cyanide m-Chlorophenyldrazone (cccp, Merck Millipore, Molsheim, France)^[@bib50]^ or 50 *μ*M Mitochondrial Division Inhibitor-1 (mdivi-1, Merck Millipore)^[@bib51]^ for 24 h prior to and during the co-culture.

Inhibition of stem cell autophagy, HO-1 and mitochondrial biogenesis during co-culturing
----------------------------------------------------------------------------------------

To inhibit autophagy, MSCs were treated for 3 h with chloroquine (100 *μ*M, Sigma-Aldrich) prior to the co-culture.^[@bib52]^ Heme oxygenase activity or mitochondrial biogenesis was inhibited in MSC by adding SnPPIX (10 *μ*M, Frontier Scientific, Franckfurt, Germany)^[@bib53]^ or ddC (100 *μ*M; Abcam, Paris, France),^[@bib32]^ respectively, to the co-culture.

Bidirectional exchanges of mitochondria and mitochondrial biogenesis assessment by flow cytometry
-------------------------------------------------------------------------------------------------

To assess mitochondria transfer from MSC to somatic cells or from somatic to MSC, MSC or somatic cells were, respectively, labeled with MitoTracker Green FM (40 nM, Invitrogen) prior to the co-culture. To determine ROS level released by somatic mitochondria transferred to MSC, somatic cells were labeled with Mitosox (1.25 *μ*M, Invitrogen) prior to the co-culture. Mitochondrial exchanges and ROS produced by transferred somatic mitochondria were evaluated by flow cytometry 24 h after co-culturing.

To measure the mitochondrial mass of MSC after 24 h co-culture with healthy or injured somatic cells, MitoTracker Green (20 nM) was added at the end of the co-culture and its fluorescence was analyzed by flow cytometry on the WGA^+^ cell population corresponding to MSC.

Oxygen consumption measurements in living somatic *ρ*0 cells
------------------------------------------------------------

Pericellular measurements of oxygen were achieved by detection of the oxygen concentration in *ρ*0 somatic cells, after flow cytometry selective separation from co-cultivated MSC in real-time using a Sensor Dish Reader (PreSens, Regensburg, Germany). Briefly, somatic cells alone or following co-culture and selective separation from MSC were seeded in a 24-well plates (10^5^ cells/well) coated with an oxygen detection probe (Oxodish), and changes in oxygen concentrations were recorded continuously for 16 h as previously reported.^[@bib54]^

Flow cytometry detection of somatic cell apoptosis following an H~2~O~2~ insult
-------------------------------------------------------------------------------

Twenty-four hours following H~2~O~2~ or Doxorubicin insult, somatic RL14 or HUVEC cells grown alone or in co-cultures were stained with Annexin V conjugated to Phycoerythrin and 7AAD (BD Pharmingen, Le Pont de Claix, France) according to the manufacturer's protocol and were analyzed by flow cytometry. The number of living somatic cells was obtained by counting the double-negative-stained cells in the gated WGA^−^ population and expressed as the percentage of the total cell count.

Flow cytometry quantification of MSC autophagy activity and expression of HO-1 and mtTFA
----------------------------------------------------------------------------------------

The autophagy activity of MSC was quantified 24 h after co-cultures with either naive or injured somatic cells with H~2~O~2~ or doxorubicin by staining with × 500-diluted CytoID green solution (Enzo Life Sciences, Villeurbane, France) for 30 min and analysis of fluorescence by flow cytometry in the gated WGA^+^ population corresponding to stem cells. Cleavage of cytosolic LC3-I from autophagosome-associated LC3II was evaluated by flow cytometry following staining with the Muse Autophagy LC3-antibody-based kit (Merck Millipore) according to the manufacturer's instructions. Autophagosome clearance was assessed after cell fixation and permeabilization using the Cytofix/Cytoperm Fixation/Permeablization kit (BD Pharmingen) followed by staining with alexa Fluor 488-conjugated rabbit monoclonal antibody to SQSTM1/p62 (clone EPR4844, Abcam) and flow cytometry analysis.

Flow cytometry quantification of HO-1 and mtTFA protein expression
------------------------------------------------------------------

Protein expression of HO-1 and mtTFA was quantified 24 h after co-cultures of MSC with either naive or Doxorubicin-injured somatic cells after cell fixation and permeabilization using Cytofix/Cytoperm Fixation/Permeabilization kit (BD Pharmingen) followed by intercellular staining with phycoerytrin-conjugated mouse monoclonal anti-HO-1 antibody (Abcam) or Alexa fluor 488-conjugated mouse monoclonal anti-mtTFA antibody (clone18G102B2E11, Abcam) and flow cytometry analysis.

Transmission electron microscopy
--------------------------------

MSCs co-cultured with H~2~O~2~-injured RL14 or HUVEC cells were fixed overnight in 3% glutaraldehyde in 0.1 M sodium phosphate buffer, pH 7.4, post-fixed for 1.5 h with 1% osmium tetraoxide, dehydrated by successive ethanol washes (70%, 90%, 100%, 100%) and impregnated with epoxy resin. After polymerization, 80- to 90-nm sections were cut by use of a Reichert Ultracut S ultramicrotome, stained with 2% uranyl acetate plus Reynold's lead citrate and visualized under a JEOL 1011 transmission electron microscope with GATAN Erlangshen CCD camera.

Measurement of heme oxygenase activity
--------------------------------------

MSCs co-cultured with naive or H~2~O~2~-treated RL14 or HUVEC cells were collected for heme oxygenase activity after 24 h. The assay is based on the spectrophotometric determination of bilirubin as the final product of heme degradation by heme oxygenase as already described by our group.^[@bib8]^ Samples were incubated with the substrate hemin, NADPH, liver cytosol (a source of biliverdin reductase) and other co-factors to sustain heme oxygenase activity. The reaction was allowed to proceed for 1 h at 37 °C in the dark and was terminated by addition of chloroform to extract the bilirubin produced. Bilirubin was measured spectrophotometrically, calculated in picomoles bilirubin/mg protein/60 min and then expressed as percentage of control.

Immunocytochemistry
-------------------

Cells were fixed with 4% PFA and stained with antibodies (Ab) against HO-1 (rabbit polyclonal Ab (pAb), 1:50, Enzo Life Sciences), LC3B (rabbit pAb, 1:500, Abcam), mtTFA (mouse monoclonal Ab, 1:100, Abcam) or human mitochondria (mouse mAb, 1:100, Abcam). Donkey secondary anti-rabbit or -mouse Ab (FITC- or Cy3-conjugated, 1:100) were purchased from Jackson ImmunoResearch Laboratories Inc. (Montlucon, France) Nuclei were stained with Hoechst 33342 (Sigma-Aldrich). Fluorescence was analyzed with a Zeiss Axioplan 2 Imaging microscope (Carl Zeiss, Marly le Roy, France). Measurement of fluorescence was calculated using ImageJ according to the formula 'corrected total cell fluorescence=integrated density−(area of selected cell × mean fluorescence of background readings)'.

Isolation and delivery of somatic mitochondria to MSC
-----------------------------------------------------

Mitochondria were isolated from RL14 cells using the Pierce Mitochondria Isolation Kit (Pierce Chemical Co, Rockford, IL, USA) following the manufacturer\'s instructions. Mitochondria from 20 × 10^6^ naive or *ρ*0 RL14 cells were mixed with 0.06 mg Pep-1 (Eurogentec, SERAING, Belgium) for 20 min at room temperature as previously reported.^[@bib35]^ Pep-1-conjugated somatic mitochondria were then incubated with MSC or somatic naive or *ρ*0 cells for 24 h (mitochondria from 3 × 10^6^ RL14 cells were used to treat 150 000 cells).

Real-time PCR assays
--------------------

PCR assays were performed in samples from MSC co-cultured with HUVEC cells (followed by CD31 negative magnetic bead isolation) or treated with exogenous mitochondria or from healthy or infarcted mouse hearts collected 1 day after delivery of MSC or HBSS. RNA extraction was performed using TRIzol reagent (Invitrogen), according to the manufacturer's instructions, and then reverse-transcribed using the Superscript First-Strand Synthesis System (Invitrogen) and random primers. Specificity of primer sets was assessed using mouse or human universal RNA (Clontech, Saint Germain en Laye, France). Quantitative RT-PCR reactions were performed in triplicate on a 7900 real-time PCR detection system (Applied Biosystems, Waltham, MA, USA) using Platinum SYBR Green qPCR SuperMix (Invitrogen) for transcriptional expression of human HO-1 (Forward 5′-TTCTTCACCTTCCCCAACATTG-3′ Reverse 5′-CAGCTCCTGCAACTCCTCAAA-3′) and human miro-1 (HP227589, Origene) or Taqman universal Mix (Applied Biosystem) for transcriptional expression of human PGC1*α* (Hs01082775-m1, Applied Biosystem) and human mtTFA (H 01016730-g1, Applied Biosystem). Human SFA3A1 (Forward 5′-TGCAGGATAAGACGGAATCCAAA-3′ and Reverse 5′-GTAGTAAGCCAGTGAGTTGGAATCTTTG-3′) and human GAPDH (Hs00266705-g1, Applied Biosystems) were used as reference genes for SYBR or Taqman amplifications, respectively.

Mouse myocardial infarction and cell injections
-----------------------------------------------

All procedures were performed in accordance with the principles and guidelines established by the European Convention for the Protection of Laboratory Animals and were approved by the Lyon 1 Claude Bernard University Committee for animal research. Myocardial infarction was induced in 10--12-week-old male C57BL6/J mice (Charles River Laboratories, L'arbresle, France) by occluding the left coronary artery for 45 min followed by reperfusion for 10 min. After surgery, a 20 *μ*l HBSS solution containing \~4.0 × 10^5^ naive MSC or MSC previously treated with chloroquine (100 *μ*M) or SnPPIX (10 *μ*M) was injected into the myocardium surrounding the infarcted site. Simultaneously to intracardiac delivery of MSC previously treated with SnPPIX, mice received an intraperitoneal injection of SnPPIX (15 mg/kg). In control experiments, similar cell injections were performed in intact mouse hearts or infarcted mouse hearts received the same amount of HBSS. Injections were performed under a Zeiss microscope.

Quantification of Troponin I in mouse serum
-------------------------------------------

Measurement of troponin I in the serum of infarcted mice was used for specific evaluation of cardiomyocytes' death according to the manufacturer's instructions (Architect Stat Troponin-I Abbott), using anti-troponin I primary antibody and acrinidium-coupled secondary antibody.

Western blots
-------------

Mouse ischemic heart area was lysed with Precellys 24 (parameters: 6,000 r.p.m.: 3 × 10 s) in buffer containing 1% Triton X-100, 50 mM Tris, 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT, 5 mM EDTA and supplemented with a cocktail of protease inhibitors (Sigma-Aldrich) and phosphatase inhibitors (PhosphoStop, Roche Diagnostics, Meylan, France).

Lysate protein concentration was determined by the bicinchoninic acid method (Interchim, Montlucon, France). After migration in sodium dodecyl sulfate 15% polyacrylamide gel (SDS-PAGE), proteins (100 *μ*g per sample) were blotted to polyvinylidene difluoride membranes by electrotransfer (Trans-Blot Turbo Transfer, Bio-Rad). Protein membranes were then incubated with a primary antibody recognizing both total and cleaved forms of caspase-3 (Cell Signaling, Saint Quentin Yvelines, France, 9662) followed by a secondary horseradish peroxidase antibody. Detection was carried out with an ECL kit (GE Healthcare) and band quantification was carried out using the ImageLab software (Bio-Rad, Mitry-Mori, France).

Statistical analysis
--------------------

Data analysis was performed using GraphPad Prism software version 5.0 (San Diego, CA, USA). Data are expressed as mean±S.E.M., and for statistical analysis one-way ANOVA combined with Bonferroni multiple comparison tests were applied. *P*-values smaller than 0.05 were considered significant.

We are grateful to Régine Cartier (Hospices Civils de Lyon, France) for helpful technical assistance in measuring mouse plasmatic cardiac troponin, Alain Schmitt (Institut Cochin, Paris, France), for TEM experiments, and Patricia Zadigue (INSERM U955, Créteil, France) for her technical contribution in cell culture experiments. This work was supported by funding from French National Institute of Health and Medical Research (INSERM) and Association pour la Recherche et l'Etude des Maladies Cardiovasculaires (AREMCAR).
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![Mitochondria released from dying somatic cells trigger the rescue properties of MSC. (**a** and **b**) Representative flow cytometry histogram (upper panels) and relative quantification (lower panels) of transfer of MitoTracker Green-labeled mitochondria from H~2~O~2~ insulted RL14 or RL14 *ρ*0 cardiomyocytes (**a**) or -HUVEC endothelial cells (**b**) to MSC (CC-H~2~O~2~ or CC-*ρ*0 H~2~O~2~, red line) by reference to co-cultures (CCs) with untreated somatic cells (CC-NT or CC-*ρ*0 NT, black line). Gray histograms correspond to unstained MSC cultured alone. \**P*\<0.05. (**c** and **d**) Flow cytometry analysis of Annexin V/7ADD staining in WGA-gated cardiac or endothelial cells cultured alone (RL14 NT, RL14 *ρ*0 NT, HUVEC NT, HUVEC *ρ*0 NT), after an H~2~O~2~ insult (RL14 H~2~O~2~, RL14 *ρ*0 H~2~O~2~, HUVEC H~2~O~2~, HUVEC *ρ*0 H~2~O~2~) or in CC with MSC after an H~2~O~2~ insult (CC-RL14 H~2~O~2~, CC-RL14 *ρ*0 H~2~O~2~, CC-HUVEC H~2~O~2~, CC-HUVEC *ρ*0 H~2~O~2~). Lower panels represent the relative survival of RL14 or HUVEC cells after an H~2~O~2~ insult following CC with naive MSC or when a transwell insert of 0.4 (CC-TW0.4) or 1 *μ*m (CC-TW1) pore size was impeding the contact between MSC and RL14 or HUVEC, by reference to H~2~O~2~-injured somatic cells cultured alone, respectively. Relative survival of *ρ*0 somatic cells injured with H~2~O~2~ in CC (CC-RL14 *ρ*0, CC-HUVEC *ρ*0) by reference to single culture is also shown. (**a--d**) Data represent the mean±S.E.M. of at least *n*=5 independent experiments. \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001](cdd201751f1){#fig1}

![Mitochondria released from dying somatic cells improve mitochondria donor capacity of MSC. (**a** and **b**) Representative flow cytometry histograms (left panels) and relative quantification (right panels) of transfer of MitoTracker Green-labeled mitochondria from MSC to H~2~O~2~-injured RL14 and -*ρ*0 RL14 (**a**) or H~2~O~2~-injured HUVEC and -*ρ*0 HUVEC cells (**b**; red line or CC---H~2~O~2~ and CC---H~2~O~2~ *ρ*0) by reference to CCs with untreated somatic cells (black line or CC-NT and CC-NT *ρ*0). Gray histograms correspond to unstained naive somatic cells. (**c**) Relative survival of RL14 or HUVEC cells after an H~2~O~2~ insult following CC with naive MSC (CC) or with MSC depleted in mtDNA (CC-MSC *ρ*0) or pretreated with rhodamine 6G (CC-R6G) by reference to single culture (RL14, HUVEC). (**d**) Oxygen consumption rate of *ρ*0 somatic cells in single culture (RL14 *ρ*0, blue line, HUVEC *ρ*0, green line) or that isolated from a CC with MSC (CC-RL14 *ρ*0, red line, or CC-HUVEC *ρ*0, purple line). (**e**) Relative transcriptional expression of miro-1 in MSC following CC with untreated HUVEC cells (CC-NT) or HUVEC cells treated with H~2~O~2~ (CC-H~2~O~2~); CCs of MSC with untreated (CC TW-0.4, CC TW-1) or H~2~O~2~-treated HUVEC cells (CC-H~2~O~2~ TW-0.4, CC-H~2~O~2~ TW-1) in the presence of a 0.4 or 1 *μ*m pore size transwell insert, respectively; CCs of MSC with untreated HUVEC *ρ*0 (CC HUVEC *ρ*0) or H~2~O~2~-treated *ρ*0 HUVEC cells (CC-H~2~O~2~ HUVEC *ρ*0). Data represent the mean±S.E.M. of at least *n*=5 independent experiments. \**P*\<0.1; \*\**P*\<0.01; \*\*\**P*\<0.001](cdd201751f2){#fig2}

![Degradation of somatic-derived mitochondria by MSC is required for apoptotic cell rescue. (**a**) Left panel: transmission electron microscopy showing depolarized mitochondria (star) in a phagosome-like vesicle (arrow). Scale bar, 200 *μ*m. Middle panel: fluorescence microscopy showing mitochondria (green signal) co-localized with autophagosome-LC3B marker (red signal) in WGA^+^ MSC (white signal) subjected to CC with H~2~O~2~-treated RL14 cells. Nuclei were counterstained with Hoechst 33342 (blue). Scale bar, 50 *μ*m. Right panel: magnification of the square area shown in the middle picture. Scale bar, 50 *μ*m. (**b** and **c**) Upper panels: LC3B immunostaining (red signal; left panels) and fluorescence quantification in WGA^+^ MSC (white signal) and WGA^−^ RL14 or HUVEC cells following CC in the absence (CC-NT) or following an H~2~O~2~ treatment (CC-H~2~O~2~; right panels). Nuclei were counterstained with DAPI (blue). Scale bar, 50 *μ*m. Lower panels: relative flow cytometry quantification of autophagy activity in MSC following CCs with H~2~O~2~-treated somatic cells (CC-H~2~O~2~) by reference to untreated ones (CC-NT) or CCs with H~2~O~2~-treated *ρ*0 somatic cells (CC-H~2~O~2~ *ρ*0) by reference to untreated ones (CC-NT *ρ*0) or CCs of H~2~O~2~-treated somatic cells (CC-H~2~O~2~ TW) by reference to untreated ones in the presence of a transwell insert (CC-NT TW). (**d** and **e**) Left panels: representative dot blots of flow cytometry analysis of Annexin V/7ADD staining on WGA^−^ gated somatic cells in single culture after an H~2~O~2~ insult (RL14, HUVEC), in CC with naive MSC after an H~2~O~2~ insult (CC-RL14, CC-HUVEC) or in CC with MSC pretreated with chloroquine prior to the CC (CC-Chloro). Right panels: relative survival of RL14 or HUVEC cells after an H~2~O~2~ insult following CC with naive (CC) or chloroquine-treated MSC (CC-Chloro) by reference to single culture (Alone). (**b--e**) Data represent the mean±S.E.M. of at least *n*=4 independent experiments. \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001](cdd201751f3){#fig3}

![Degradation of somatic-derived mitochondria stimulate the anti-apoptotic function of MSC through HO-1 induction. (**a**) HO-1 immunostaining (red signal; left panels) and fluorescence quantification in WGA^+^ MSC (white signal) and WGA^−^ RL14 or HUVEC cells following CC in the absence (CC-NT) or following an H~2~O~2~ treatment (CC-H~2~O~2~; right panels). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar, 50 *μ*m. (**b** and **c**) Relative HO-1 mRNA expression (HUVEC cells only; **c**) and relative heme oxygenase activity (**c**) assessed in MSC co-cultured with H~2~O~2~-treated (CC-H~2~O~2~) by reference to untreated (CC-NT) RL14 or HUVEC cells, H~2~O~2~-treated (CC-H~2~O~2~ *ρ*0) by reference to untreated *ρ*0 RL14 or HUVEC cells (CC-NT *ρ*0) or CC of chloroquine-treated MSC with H~2~O~2~-treated (CC-H~2~O~2~ Chloro) by reference to untreated RL14 or HUVEC cells (CC-NT Chloro). (**d** and **e**) Representative dot blots of flow cytometry analysis of Annexin V/7ADD staining (left panels) and relative quantification of survival (right panels) on gated WGA^−^ somatic cells after an H~2~O~2~ insult in CC with MSC in the absence (CC-RL14, CC-HUVEC) or presence of SnPPIX (CC-RL14+SnPPIX, CC-HUVEC+SnPPIX) by reference to single culture in the absence (RL14, HUVEC) or presence of SnPPIX (RL14+SnPPIX, HUVEC+SnPPIX), respectively. (**b--e**) Data represent the mean±S.E.M. of at least *n*=4 independent experiments. \**P*\<0.1; \*\**P*\<0.01; \*\*\**P*\<0.001](cdd201751f4){#fig4}

![HO-1 induction following somatic-derived mitochondria degradation leads to stimulation of mitochondrial biogenesis in MSC. (**a**) Relative quantification of the MSC mitochondrial mass following CC with untreated (black line) or H~2~O~2~-treated RL14 or HUVEC cells (red line). Gray histograms: fluorescence of MSC grown alone. (**b**) Relative PGC-1*α* and mtTFA mRNA expression in co-cultivated MSC. (**a** and **b**) Data represent the mean±S.E.M. of at least *n*=4 independent experiments. \*\*\**P*\<0.001. (**c** and **d**) mtTFA immunocytochemistry (green signal, left panels) and fluorescence quantification in co-cultivated WGA^+^ MSC (white signal) and WGA^−^ somatic cells (right panels). Nuclei were counterstained with Hoechst 33342 (blue). Scale bar, 50 *μ*m. (**a--d**) CC-NT: CC with untreated somatic cells; CC-H~2~O~2~: CC with H~2~O~2~-treated somatic cells; CC-NT *ρ*0 and CC-H~2~O~2~ *ρ*0: CCs with *ρ*0 somatic cells; CC-NT Chloro and CC-H~2~O~2~ Chloro; CCs of MSC pretreated with chloroquine; CC-NT SnPPIX and CC-H~2~O~2~ SnPPIX: CCs in the presence of SnPPIX. (**e** and **f**) Representative dot blots of flow cytometry analysis of Annexin V/7ADD staining (left panels) and relative quantification of survival (right panels) on gated WGA^−^ cardiac (**e**) or endothelial (**f**) cells after an H~2~O~2~ insult in CC in the presence of ddC (CC+ddC) by reference to single culture in the presence of ddC (RL14+ddC, HUVEC+ddC). Data represent the mean±S.E.M. of at least *n*=5 independent experiments. \**P*\<0.05; \*\**P*\<0.01](cdd201751f5){#fig5}

![ROS and mitochondrial dynamic are involved in the rescue of doxorubicin-damaged somatic cells by MSC. (**a**) Representative flow cytometry histogram (left panels) and relative quantification (right panels) of transfer of MitoTracker Green-labeled mitochondria from doxorubicin-insulted RL14 cardiomyocytes or -HUVEC endothelial cells to MSC (CC-Dox, red line) by reference to CCs with untreated somatic cells (CC-NT, black line). Gray histograms correspond to unstained MSC cultured alone. \*\**P*\<0.01. (**b**) Representative dot blots of flow cytometry analysis of Annexin V/7ADD staining (left panels) and relative quantification of survival (right panels) on gated WGA^−^ somatic cells after doxorubicin insult, in single culture (RL14 Dox, HUVEC Dox) or in CC with MSC (CC-Dox) without treatment or following exposure to NAC (+NAC), mdivi-1 (+mdivi-1) or cccp (+cccp). (**c**) Flow cytometry-relative quantification of transfer of MitoTracker Green-labeled mitochondria from MSC to doxorubicin-injured RL14 (upper panel) or -HUVEC cells (lower panel; CC-Dox) by reference to CCs with untreated somatic cells (CC-NT). (**d**) Relative flow cytometry quantification of autophagy activity in MSC following CCs with doxorubicin-treated somatic cells (CC-Dox) by reference to untreated ones (CC-NT). (**e** and **f**) Representative flow cytometry histogram (left panels) and relative quantification (right panels) of HO-1 (**e**) and mtTFA (**f**) in MSC following CCs with doxorubicin-treated somatic cells (CC-Dox) by reference to untreated ones (CC-NT). Gray histograms correspond to unstained naive somatic cells. (**g**) Representative flow cytometry histogram (left panels) and relative quantification (right panels) of transfer of Mitosox-labeled mitochondria from doxorubicin-insulted RL14 cardiomyocytes or -HUVEC endothelial cells to MSC (CC-Dox, red line) by reference to CCs with untreated somatic cells (CC-NT, black line). Gray histograms correspond to unstained MSC cultured alone. (**a--f**) Data represent the mean±S.E.M. of at least *n*=4 independent experiments. \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001. CC with MSC following exposure to NAC (+NAC), mdivi-1 (+mdivi-1) or cccp (+cccp)](cdd201751f6){#fig6}

![Exposure of MSC to exogenous mitochondria isolated from somatic cells mimics the effects of co-culturing. (**a**) LC3B immunocytochemistry (left panels) and fluorescence quantification (right panels) in MSC alone (untreated) or exposed to cardiac mitochondria (+Mitochondria) without treatment (naive) or after chloroquine (Chloro) or SnPPIX treatment (SnPPIX). (**b**) Representative flow cytometry histogram (left panels) and relative quantification (right panels) of cleaved LC3-II or p62 in MSC alone (black line) or MSC exposed to cardiac mitochondria (red line). Gray histograms: fluorescence of MSC stained with respective control IgG antibody. (**c**) HO-1 immunocytochemistry (left panels) and fluorescence quantification (right panels) in MSC alone (Mito−) or MSC exposed to cardiac mitochondria (Mito+) without treatment (naive) or after Chloro or SnPPIX. (**d**) Relative heme oxygenase activity in MSC exposed to cardiac mitochondria (Mito+) by reference to MSC grown alone (Mito−) without treatment (naive) or after Chloro or SnPPIX. (**e**) Immunocytochemistry showing mtTFA protein expression (green signal, left panels) and fluorescence quantification in MSC exposed to cardiac mitochondria (Mito+) by reference to MSC grown alone (Mito−) without any treatment (naive) or after Chloro or SnPPIX. (**f**) Relative PGC1-*α* and mtTFA mRNA expression in MSC exposed to cardiac mitochondria (Mito+) by reference to MSC grown alone (Mito−) without treatment (naive) or after Chloro or SnPPIX. (**g**) Relative flow cytometry quantification of autophagy activity and protein expression for HO-1 and mtTFA in MSC treated with cardiac *ρ*0 mitochondria (Mito *ρ*0+) by reference to untreated MSC (Mito *ρ*0−). (**h**) Relative flow cytometry quantification of Annexin V^−^/7ADD^−^ cardiac or endothelial *ρ*0 cells after an H~2~O~2~ insult in CC with MSC previously treated with cardiac naive (CC+Mito) or *ρ*0 mitochondria (CC+Mito *ρ*0) by reference to single culture (Alone). (**a**, **c** and **e**) Nuclei were counterstained with Hoechst 33342 (blue). Scale bar, 50 *μ*m. (**b, d** and **f--h**) Data represent the mean±S.E.M. of at least *n*=4 independent experiments. \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001](cdd201751f7){#fig7}

![MSC delivery in mice protects infarcted hearts through autophagy- and HO-1-dependent mechanisms. (**a**) Transcriptional expression of HO-1, PGC1-*α* and mtTFA in MSC following their engraftment into infarcted hearts of mice (MI) either alone (naive) or in the presence of chloroquine (MSC Chloro) or SnPPIX (MSC SnPPIX) treatment. Data represent the mean±S.E.M. of at least *n*=5 mice per group and are expressed compared to sham-treated hearts (Sham). \*\**P*\<0.01; \*\*\**P*\<0.001. (**b**) Quantification of plasmatic cardiac troponin 24 h after myocardial infarction in mice treated with HBSS, naive MSC or MSC in the presence of chloroquine or SnPPIX. Data represent the mean±S.E.M. of at least *n*=10 mice per group. \**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001. (**c**) Ratio of cleaved/total caspase 3 protein expression in infarcted hearts of mice treated with HBSS, naive MSC or MSC in the presence of chloroquine or SnPPIX. Western blots were performed 24 h after myocardial infarction and cell delivery. Data represent the mean±S.E.M. of at least *n*=5 mice per group. \**P*\<0.05; \*\*\**P*\<0.001](cdd201751f8){#fig8}
